Karp Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-57,171
| Closed | -$2.93M | – | 109 |
|
|
2019
Q1 | $2.93M | Buy |
57,171
+2,670
| +5% | +$137K | 1.04% | 40 |
|
|
2018
Q4 | $2.56M | Sell |
54,501
-4,377
| -7% | -$205K | 1.22% | 32 |
|
|
2018
Q3 | $3.29M | Sell |
58,878
-1,482
| -2% | -$82.9K | 1.13% | 34 |
|
|
2018
Q2 | $3.05M | Buy |
60,360
+52,860
| +705% | +$2.67M | 1.2% | 36 |
|
|
2018
Q1 | $369K | Hold |
7,500
| – | – | 0.15% | 104 |
|
|
2017
Q4 | $386K | Hold |
7,500
| – | – | 0.16% | 101 |
|
|
2017
Q3 | $391K | Sell |
7,500
-825
| -10% | -$43K | 0.18% | 94 |
|
|
2017
Q2 | $430K | Sell |
8,325
-360
| -4% | -$18.6K | 0.21% | 83 |
|
|
2017
Q1 | $437K | Hold |
8,685
| – | – | 0.25% | 74 |
|
|
2016
Q4 | $409K | Sell |
8,685
-225
| -3% | -$10.6K | 0.27% | 68 |
|
|
2016
Q3 | $444K | Hold |
8,910
| – | – | 0.28% | 70 |
|
|
2016
Q2 | $429K | Sell |
8,910
-8,100
| -48% | -$390K | 0.29% | 67 |
|
|
2016
Q1 | $777K | Sell |
17,010
-5,565
| -25% | -$254K | 0.54% | 58 |
|
|
2015
Q4 | $1.22M | Sell |
22,575
-9,945
| -31% | -$536K | 0.71% | 54 |
|
|
2015
Q3 | $1.61M | Buy |
32,520
+10,890
| +50% | +$537K | 1.1% | 35 |
|
|
2015
Q2 | $1.26M | Buy |
21,630
+960
| +5% | +$55.9K | 0.85% | 41 |
|
|
2015
Q1 | $1.19M | Buy |
20,670
+300
| +1% | +$17.2K | 0.81% | 42 |
|
|
2014
Q4 | $1.03M | Buy |
+20,370
| New | +$1.03M | 0.75% | 43 |
|